Sign In
Buy IONS
$73.82
+0.85 (+1.16%)
At Close: Jun 03, 2026
Biogen Announces First Patient Treated With Higher Dose of SPINRAZA (nusinersen)in Phase 2/3 DEVOTE Study
11:30am, Thursday, 02'nd Apr 2020
Biogen (BIIB) today announced that the first patient has been treated in the global clinical study, DEVOTE. The study is designed to evaluate the safety, tolerability and potential for even greater e
Biogen Announces First Patient Treated With Higher Dose of SPINRAZA (nusinersen)in Phase 2/3 DEVOTE Study
11:30am, Thursday, 02'nd Apr 2020
DEVOTE will evaluate the safety and potential for even greater efficacy of a higher dose of SPINRAZA in the treatment of spinal muscular atrophy...
Analysts Expect Ionis Pharmaceuticals Inc (NASDAQ:IONS) to Announce -$0.05 EPS
07:46am, Thursday, 02'nd Apr 2020
Brokerages predict that Ionis Pharmaceuticals Inc (NASDAQ:IONS) will report earnings of ($0.05) per share for the current quarter, according to Zacks Investment Research. Seven analysts have made esti
